Different effects of a single amino acid substitution on three adjacent epitopes in the gp41 C-terminal tail of a neutralizing antibody escape mutant of human immunodeficiency virus type 1

Archives of Virology

Volumn 146, Issue 1, 2001, Pages 157-166

  McLain, L ^a   Brown, J L ^a   Cheung, L ^a   Reading, S A ^a   Parry, C ^a   Jones, T D ^b   Cleveland, S M ^a   Dimmock, N J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b Axis Genetics plc   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ANTIBODY SPECIFICITY; CARBOXY TERMINAL SEQUENCE; EPITOPE; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE PROTEIN; MUTANT PROTEIN;

AMINO ACID SUBSTITUTION; AMINO ACIDS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MACROMOLECULAR SUBSTANCES; MUTAGENESIS, SITE-DIRECTED; NEUTRALIZATION TESTS; PEPTIDES; PROTEIN BINDING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035092528     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050170199     Document Type: Article

References (42)

1. A trimeric structural domain of the HIV-1 transmembrane glycoprotein
2. A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein
3. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
4. Atomic structure of the ectodomain from HIV-1 gp41
5. Core structure of gp41 from the HIV envelope glycoprotein
6. Membrane interactions of human immunodeficiency virus: Attachment, fusion, and cytopathology
7. Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1
8. Properties of a neutralizing antibody that recognises a conformational form of epitope ERDRD in the C-terminal tail of human immunodeficiency virus type 1
9. Immunogenic and antigenic dominance of a non-neutralizing epitope over a highly conserved neutralizing epitope in the gp41 transmembrane envelope glycoprotein of HIV-1: Its deletion leads to a strong neutralizing antibody response
10. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody
11. Mapping the topology of the human immunodeficiency virus glycoprotein gp120 with a panel of monoclonal antibodies
12. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
13. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
14. Epitopes exposed on functional, oligomeric gp41 molecules
15. Complete nucleotide sequence of the AIDS virus, HTLV-III
16. Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein
17. Computer assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: Prediction of antigenic epitopes in conserved and variable regions
18. An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies
19. Expression and immunogenicity of an 18-residue epitope of HIV-1 gp41 inserted in the flagellar protein of a Salmonella live vaccine
20. Human immunodeficiency virus type 1 neutralizing antibodies raised to a gp41 peptide expressed on the surface of a plant virus
21. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22-mer amino acid peptide expressed on the surface of a plant virus
22. A plant virus-HIV-1 chimera stimulates antibody that neutralizes HIV-1
23. Induction of anti-HIV neutralizing antibodies by synthetic peptides
24. Immunogenicity of recombinant influenza virus haemagglutinin carrying peptides from the envelope protein of human immunodeficiency virus type 1
25. Differences in the antibody response to human immunodeficiency virus type 1 envelope protein (gp160) in infected laboratory workers and vaccinees
26. Effect of non-protective vaccination on antibody response to subsequent human immunodeficiency virus infection
27. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies
28. Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera
29. The neutralizing antibody response against a conserved region of HIV-1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope
30. Construction and in vitro properties of HIV-1 mutants with deletions in 'non-essential' genes
31. Neutralization of animal viruses
32. Amino acid changes outside the G-H loop of capsid protein of type O foot-and-mouth disease virus confer resistance to neutralization by anti-peptide G-H serum
33. Characterization of HIV-1 neutralization escape mutants
34. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees
35. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582 (→Thr)) decreases viral neutralization by monoclonal antibodies
36. Spontaneous reversion of human immunodeficiency virus type 1 neutralization resistant variant HXB2thr582: In vitro selection against cytopathicity highlights gp120-gp41 interactive regions
37. Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites
38. Natural feline leukemia virus variant escapes neutralization by a monoclonal antibody via an amino acid change outside the antibody binding epitope
39. Single amino acid changes in the S2 subunit of the MHV surface glycoprotein confer resistance to neutralization by S1 subunit-specific monoclonal antibody
40. Theoretically determined three-dimensional structure for amphipathic segments of the HIV-1 gp41 envelope protein
41. Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies